Table 2.
% SARS CoV-2 tested | ||||||||
Labs only | Labs + reported diagnoses | |||||||
PWH | PWoH | PWH | PWoH | |||||
% | % | Difference | p-value * | % | % | Difference | p-value * | |
Cohort 1 | 40.5% | 28.2% | 12.3% | <0.001 | ||||
Cohort 2 | 28.5% | 23.3% | 5.2% | <0.001 | 30.5% | 25.5% | 5.0% | <0.001 |
Cohort 3 | 36.7% | 29.4% | 7.3% | <0.001 | 37.1% | 29.7% | 7.4% | <0.001 |
Cohort 4 | 19.6% | 14.8% | 4.8% | <0.001 | 21.8% | 16.2% | 5.6% | <0.001 |
Cohort 5 | 23.6% | 16.8% | 6.8% | <0.001 | 24.3% | 18.2% | 6.2% | <0.001 |
Cohort 6 | 34.4% | 34.8% | −0.3% | 0.835 | ||||
% SARS CoV-2 positive | ||||||||
Labs only | Labs + reported diagnoses | |||||||
PWH | PWoH | PWH | PWoH | |||||
% | % | Difference | p-value * | % | % | Difference | p-value * | |
Cohort 1 | 9.1% | 11.6% | −2.4% | <0.001 | ||||
Cohort 2 | 10.0% | 9.8% | 0.1% | 0.737 | 12.9% | 13.9% | −0.9% | 0.026 |
Cohort 3 | 17.7% | 16.3% | 1.4% | 0.143 | 19.0% | 17.4% | 1.5% | 0.118 |
Cohort 4 | 3.6% | 8.2% | −4.7% | <0.001 | 10.5% | 14.9% | −4.4% | <0.001 |
Cohort 5 | 9.1% | 10.0% | −0.9% | 0.543 | 12.4% | 17.5% | −5.1% | 0.007 |
Cohort 6 | 8.2% | 4.4% | 3.7% | 0.009 |
χ2 p-values for differences in proportions
Abbreviations: PWH= Persons with HIV; PWoH= Persons without HIV